Amelia Deitchman • UCSF Profiles (original) (raw)

  1. Correlates of HIV-1 control after combination immunotherapy. Nature. 2026 02; 650(8100):187-195. Peluso MJ, Sandel DA, Deitchman AN, Kim SJ, Dalhuisen T, Tummala HP, Tibúrcio R, Zemelko L, Borgo GM, Singh SS, Schwartz K, Deswal M, Williams MC, Hoh R, Shimoda M, Narpala S, Serebryannyy L, Khalili M, Vendrame E, SenGupta D, Whitmore LS, Tisoncik-Go J, Gale M, Koup RA, Mullins JI, Felber BK, Pavlakis GN, Reeves JD, Petropoulos CJ, Glidden DV, Spitzer MH, Gama L, Caskey M, Nussenzweig MC, Chew KW, Henrich TJ, Yukl SA, Cohn LB, Deeks SG, Rutishauser RL. PMID: 41326736; PMCID: PMC12872443.
    View in: PubMed Mentions:
  2. Dynamic PET imaging predicts broadly neutralizing antibody distribution and HIV prevention efficacy. medRxiv. 2025 Nov 28. Chu DHT, Kuo-Esser L, Beckford-Vera DR, Flavell RR, Seo Y, VanBrocklin H, Henrich TJ, Deitchman AN. PMID: 41358285; PMCID: PMC12676406.
    View in: PubMed Mentions:
  3. Brief Report: Sex and HIV Modify Immune Activation Biomarkers in Ugandans Post-Tuberculosis. J Acquir Immune Defic Syndr. 2025 Oct 01; 100(2):137-142. Abelman RA, Fitzpatrick J, Zawedde J, Beck-Engeser G, Sanyu I, Marzan F, Byanyima P, Ambayec GC, Kaswabuli S, Musisi E, Sessolo A, Velasquez E, Lalitha R, Byanova KL, Aweeka FT, Deitchman AN, Lin J, Davis JL, Crothers K, Worodria W, Hunt PW, Huang L. PMID: 40530901; PMCID: PMC12382825.
    View in: PubMed Mentions: Fields:
    Translation:Humans
  4. Phase I Trial to Evaluate the Safety of Intralesional Nivolumab Therapy for Limited Cutaneous Kaposi Sarcoma. JCO Oncol Adv. 2025; 2(1):e2400098. Wang CJ, Bang A, Chowdhury S, Leslie KS, Lang UE, Shimoda M, Henrich TJ, Hoh R, Deeks SG, Wang C, Deitchman AN, Couey P, Maurer T. PMID: 40655531; PMCID: PMC12244976.
    View in: PubMed Mentions:
  5. COVID-19 clinical presentation, management, and epidemiology: a concise compendium. Front Public Health. 2025; 13:1498445. Maison DP, Tasissa H, Deitchman A, Peluso MJ, Deng Y, Miller FD, Henrich TJ, Gerschenson M. PMID: 39957982; PMCID: PMC11826932.
    View in: PubMed Mentions: 8 Fields:
    Translation:HumansCellsPHPublic Health
  6. Characterizing safety, toxicity, and breast cancer risk reduction using a long-term fulvestrant eluting implant. Sci Rep. 2025 01 24; 15(1):3028. Thomas S, Roche E, Desai P, Pawlowska N, Bauer D, Gingrich D, Hsu E, Deitchman AN, Aweeka F, Munster PN. PMID: 39848945; PMCID: PMC11758070.
    View in: PubMed Mentions: Fields:
    Translation:Animals
  7. Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV. Cell Rep Med. 2024 Oct 15; 5(10):101745. Henrich TJ, Bosch RJ, Godfrey C, Mar H, Nair A, Keefer M, Fichtenbaum C, Moisi D, Clagett B, Buck AM, Deitchman AN, Aweeka F, Li JZ, Kuritzkes DR, Lederman MM, Hsue PY, Deeks SG, ACTG A5337 Team. PMID: 39321793; PMCID: PMC11513808.
    View in: PubMed Mentions: 3 Fields:
    Translation:HumansCells
  8. The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms. J Med Virol. 2023 11; 95(11):e29216. Buck AM, Deitchman AN, Takahashi S, Lu S, Goldberg SA, Bodansky A, Kung A, Hoh R, Williams MC, Kerbleski M, Maison DP, Deveau TM, Munter SE, Lombardo J, Wrin T, Petropoulos CJ, Durstenfeld MS, Hsue PY, Kelly JD, Greenhouse B, Martin JN, Deeks SG, Peluso MJ, Henrich TJ. PMID: 37988251; PMCID: PMC10754238.
    View in: PubMed Mentions: 4 Fields:
    Translation:HumansCellsPHPublic Health
  9. Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs. Eur Respir J. 2023 08; 62(2). Ernest JP, Goh JJN, Strydom N, Wang Q, van Wijk RC, Zhang N, Deitchman A, Nuermberger E, Savic RM. PMID: 37321622; PMCID: PMC10469274.
    View in: PubMed Mentions: 7 Fields:
    Translation:Animals
  10. Challenges in HIV-1 Latent Reservoir and Target Cell Quantification in CAR-T Cell and Other Lentiviral Gene Modifying HIV Cure Strategies. Viruses. 2023 05 09; 15(5). Buck AM, Deveau TM, Henrich TJ, Deitchman AN. PMID: 37243212; PMCID: PMC10222761.
    View in: PubMed Mentions: 7 Fields:
    Translation:HumansCells
  11. Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative. Front Immunol. 2023; 14:1129459. Bonilla H, Peluso MJ, Rodgers K, Aberg JA, Patterson TF, Tamburro R, Baizer L, Goldman JD, Rouphael N, Deitchman A, Fine J, Fontelo P, Kim AY, Shaw G, Stratford J, Ceger P, Costantine MM, Fisher L, O'Brien L, Maughan C, Quigley JG, Gabbay V, Mohandas S, Williams D, McComsey GA. PMID: 36969241; PMCID: PMC10034329.
    View in: PubMed Mentions: 44 Fields:
    Translation:HumansCells
  12. Chronic viral coinfections differentially affect the likelihood of developing long COVID. J Clin Invest. 2023 02 01; 133(3). Peluso MJ, Deveau TM, Munter SE, Ryder D, Buck A, Beck-Engeser G, Chan F, Lu S, Goldberg SA, Hoh R, Tai V, Torres L, Iyer NS, Deswal M, Ngo LH, Buitrago M, Rodriguez A, Chen JY, Yee BC, Chenna A, Winslow JW, Petropoulos CJ, Deitchman AN, Hellmuth J, Spinelli MA, Durstenfeld MS, Hsue PY, Kelly JD, Martin JN, Deeks SG, Hunt PW, Henrich TJ. PMID: 36454631; PMCID: PMC9888380.
    View in: PubMed Mentions: 112 Fields:
    Translation:HumansCells
  13. Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs. bioRxiv. 2023 Jan 20. Ernest JP, Ni Goh JJ, Strydom N, Wang Q, van Wijk RC, Zhang N, Deitchman A, Nuermberger E, Savic RM. PMID: 36711493; PMCID: PMC9882354.
    View in: PubMed Mentions:
  14. Evaluating the effect of atorvastatin exposure and vitamin D levels on lipid outcomes in people with HIV-1 with suppressed HIV-1 RNA and LDL cholesterol <130 mg/dL. HIV Med. 2023 06; 24(6):749-753. Rahman F, Brates I, Aweeka F, Bosch RJ, Deitchman A, Nixon D, Aberg JA. PMID: 36549898; PMCID: PMC10257730.
    View in: PubMed Mentions: Fields:
    Translation:HumansCells
  15. Female Genital Fibroblasts Diminish the In Vitro Efficacy of PrEP against HIV. Viruses. 2022 08 04; 14(8). George AF, McGregor M, Gingrich D, Neidleman J, Marquez RS, Young KC, Thanigaivelan KL, Greene WC, Tien PC, Deitchman AN, Spitzer TL, Roan NR. PMID: 36016345; PMCID: PMC9413545.
    View in: PubMed Mentions: Fields:
    Translation:HumansCells
  16. First-in-human immunoPET imaging of HIV-1 infection using 89Zr-labeled VRC01 broadly neutralizing antibody. Nat Commun. 2022 03 09; 13(1):1219. Beckford-Vera DR, Flavell RR, Seo Y, Martinez-Ortiz E, Aslam M, Thanh C, Fehrman E, Pardons M, Kumar S, Deitchman AN, Ravanfar V, Schulte B, Wu IK, Pan T, Reeves JD, Nixon CC, Iyer NS, Torres L, Munter SE, Hyunh T, Petropoulos CJ, Hoh R, Franc BL, Gama L, Koup RA, Mascola JR, Chomont N, Deeks SG, VanBrocklin HF, Henrich TJ. PMID: 35264559; PMCID: PMC8907355.
    View in: PubMed Mentions: 24 Fields:
    Translation:HumansCellsCTClinical Trials
  17. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021 08 10; 36(6):109518. Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman EA, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. PMID: 34358460; PMCID: PMC8342976.
    View in: PubMed Mentions: 146 Fields:
    Translation:HumansCells
  18. Discordant Virus-Specific Antibody Levels, Antibody Neutralization Capacity, and T-cell Responses Following 3 Doses of SARS-CoV-2 Vaccination in a Patient With Connective Tissue Disease. Open Forum Infect Dis. 2021 Aug; 8(8):ofab393. Peluso MJ, Munter SE, Lynch KL, Yun C, Torres L, Iyer NS, Donatelli J, Ryan L, Deitchman AN, Deeks SG, Rutishauser RL, Henrich TJ. PMID: 34395717; PMCID: PMC8344490.
    View in: PubMed Mentions: 3
  19. Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis. J Infect Dis. 2021 06 04; 223(11):1855-1864. Bigelow KM, Deitchman AN, Li SY, Barnes-Boyle K, Tyagi S, Soni H, Dooley KE, Savic RM, Nuermberger EL. PMID: 31993638; PMCID: PMC8176636.
    View in: PubMed Mentions: 18 Fields:
    Translation:Animals
  20. Abnormal Levels of Some Biomarkers of Immune Activation Despite Very Early Treatment of Human Immunodeficiency Virus. J Infect Dis. 2021 05 20; 223(9):1621-1630. Schnittman SR, Deitchman AN, Beck-Engeser G, Ahn H, York VA, Hartig H, Hecht FM, Martin JN, Deeks SG, Aweeka FT, Hunt PW. PMID: 32915986; PMCID: PMC8136975.
    View in: PubMed Mentions: 18 Fields:
    Translation:Humans
  21. Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV. J Acquir Immune Defic Syndr. 2020 12 15; 85(5):651-658. Gingrich D, Deitchman AN, Kantor A, Huang L, Stein JH, Currier JS, Hsue PY, Ribaudo HJ, Aweeka FT, ACTG 5314 Protocol Team. PMID: 33177476; PMCID: PMC8132144.
    View in: PubMed Mentions: 1 Fields:
    Translation:HumansCTClinical Trials
  22. Supporting Precision Dosing in Drug Labeling. Clin Pharmacol Ther. 2021 01; 109(1):37-41. Neely M, Onufrak N, Scheetz MH, Avedissian S, Lakota E, Deitchman AN, Gonzalez D. PMID: 33111328.
    View in: PubMed Mentions: 2 Fields:
    Translation:Humans
  23. Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study. Am J Transplant. 2021 05; 21(5):1765-1779. Henrich TJ, Schreiner C, Cameron C, Hogan LE, Richardson B, Rutishauser RL, Deitchman AN, Chu S, Rogers R, Thanh C, Gibson EA, Zarinsefat A, Bakkour S, Aweeka F, Busch MP, Liegler T, Baker C, Milush J, Deeks SG, Stock PG. PMID: 32780519; PMCID: PMC9177122.
    View in: PubMed Mentions: 15 Fields:
    Translation:Humans
  24. The Risk of Treating Populations Instead of Patients. CPT Pharmacometrics Syst Pharmacol. 2019 05; 8(5):256-258. Deitchman AN. PMID: 30884214; PMCID: PMC6539720.
    View in: PubMed Mentions: 1 Fields:
    Translation:HumansCells
  25. Nonlinear Protein Binding: Not What You Think. J Pharm Sci. 2018 07; 107(7):1754-1760. Deitchman AN, Singh RSP, Derendorf H. PMID: 29626534; PMCID: PMC6042850.
    View in: PubMed Mentions: 16 Fields:
    Translation:HumansAnimalsCells
  26. Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses). Circ Genom Precis Med. 2018 04; 11(4):e001854. McDonough CW, Magvanjav O, Sá ACC, El Rouby NM, Dave C, Deitchman AN, Kawaguchi-Suzuki M, Mei W, Shen Y, Singh RSP, Solayman M, Bailey KR, Boerwinkle E, Chapman AB, Gums JG, Webb A, Scherer SE, Sadee W, Turner ST, Cooper-DeHoff RM, Gong Y, Johnson JA. PMID: 29650764; PMCID: PMC5901893.
    View in: PubMed Mentions: 9 Fields:
    Translation:Humans
  27. Enhanced in vitro activity of tigecycline in the presence of chelating agents. Int J Antimicrob Agents. 2018 May; 51(5):799-802. Deitchman AN, Singh RSP, Rand KH, Derendorf H. PMID: 29305959; PMCID: PMC5940551.
    View in: PubMed Mentions: 2 Fields:
    Translation:Cells
  28. A need to revisit clinical breakpoints of tigecycline: effect of atypical non-linear plasma protein binding. Int J Antimicrob Agents. 2017 Apr; 49(4):449-455. Singh RSP, Mukker JK, Drescher SK, Deitchman AN, Derendorf H. PMID: 28237830.
    View in: PubMed Mentions: 7 Fields:
    Translation:HumansCells
  29. Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization. AAPS J. 2017 03; 19(2):334-342. Deitchman AN, Heinrichs MT, Khaowroongrueng V, Jadhav SB, Derendorf H. PMID: 27943149.
    View in: PubMed Mentions: 4 Fields:
    Translation:HumansAnimals
  30. Ceftobiprole medocaril (BAL-5788) for the treatment of complicated skin infections. Expert Rev Anti Infect Ther. 2016; 14(11):997-1006. Deitchman A, de Jong D, Barbour A, Derendorf H. PMID: 27690689.
    View in: PubMed Mentions: 1 Fields:
  31. Role of Divalent Metal Ions in Atypical Nonlinear Plasma Protein Binding Behavior of Tigecycline. J Pharm Sci. 2016 11; 105(11):3409-3414. Singh RSP, Mukker JK, Deitchman AN, Drescher SK, Derendorf H. PMID: 27616672.
    View in: PubMed Mentions: 6 Fields:
    Translation:HumansCells
  32. Measuring drug distribution in the critically ill patient. Adv Drug Deliv Rev. 2014 Nov 20; 77:22-6. Deitchman AN, Derendorf H. PMID: 25194997.
    View in: PubMed Mentions: 6 Fields:
    Translation:HumansCells
  33. Relevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage Adjustments. Ther Adv Infect Dis. 2014 Feb 01; 2(1):17-42. B?dingen FV, Gonzalez D, Tucker AN, Derendorf H. PMID: 24949199; PMCID: PMC4059611.
    View in: PubMed Mentions: 13

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.

Start with: newest oldestInclude: line numbers double spacing all authors publication IDs